572
Participants
Start Date
January 31, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
March 31, 2010
Saxagliptin
2.5 mg once daily oral dose
Placebo
Placebo
Research Site, Concord
Research Site, Sacramento
Research Site, Denver
Research Site, Topeka
Research Site, Baltimore
Research Site, Great Falls
Research Site, Greenville
Research Site, Morehead City
Research Site, Cincinnati
Research Site, Corpus Christi
Research Site, Charleston
Research Site, Brest
Research Site, Homyel
Research Site, Minsk
Research Site, Dimitrovgrad
Research Site, Sofia
Research Site, Veliko Tarnovo
Research Site, Rijeka
Research Site, Karlovac
Research Site, Osijek
Research Site, Split
Research Site, Zagreb
Research Site, Moravský Krumlov
Research Site, Prague
Research Site, Teplice
Research Site, Ústí nad Labem
Research Site, Znojmo
Research Site, Tallinn
Research Site, Dieburg
Research Site, Düsseldorf
Research Site, Hanover
Research Site, Heidelberg
Research Site, Mannheim
Research Site, Debrecen
Research Site, Győr
Research Site, Kalocsa
Research Site, Kecskemét
Research Site, Zalaegerszeg
Research Site, Riga
Research Site, Kaunas
Research Site, Klaipėda
Research Site, Panevezys
Research Site, Vilnius
Research Site, Lodz
Research Site, Bialystok
Research Site, Ciechanów
Research Site, Golub-Dobrzyń
Research Site, Grodzisk Mazowiecki
Research Site, Katowice
Research Site, Krakow
Research Site, Maków Mazowiecki
Research Site, Radom
Research Site, Szczecin
Research Site, Warsaw
Research Site, Wroclaw
Research Site, Zabrze
Research Site, Bacau
Research Site, Brasov
Research Site, Satu Mare
Research Site, Bucharest
Research Site, Sf Gheorghe
Research Site, Chelyabinsk
Research Site, Moscow
Research Site, Ryazan
Research Site, Saint Petersburg
Research Site, Yaroslavl
Research Site, Dnipropetrovsk
Research Site, Ivano-Frankivsk
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Mykolayiv
Research Site, Sumy
Research Site, Ternopil
Research Site, Zaporizhzhya
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
AstraZeneca
INDUSTRY